Tempest Therapeutics (TPST) Earnings Date & Reports

Tempest Therapeutics Inc is a late-stage develpment biotechnology company developing small molecule therapeutics to treat cancer through mechanisms that directly kill tumor cells and activate tumor-specific immunity... Show more

Industry: #Pharmaceuticals Major

Get AI intraday signals

A.I. Advisor

published Earnings

TPST is expected to report earnings to fall 88.14% to -30 cents per share on August 17

Tempest Therapeutics TPST Stock Earnings Reports

Q2'26

Est.

$-0.30

Q1'26

Missed

by $2.05

Q4'25

Missed

by $0.51

Q3'25

Missed

by $0.50

Q2'25

Missed

by $1.79

The last earnings report on May 14 showed earnings per share of -252 cents, missing the estimate of -47 cents. With 51.03K shares outstanding, the current market capitalization sits at 18.29M.

View a ticker or compare two or three

Compare

TPST

Setup

Daily Signal:

Description

Gain/Loss:

Interact to see
Advertisement

A.I.Advisor

published price charts

Last 5 trading days

View AI-Driven Trading for TPST